Dietary supplements for lipedema
- PMID: 36479502
- PMCID: PMC9710418
- DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2758
Dietary supplements for lipedema
Abstract
Lipedema is a chronic disease that mostly manifests in females as the abnormal distribution of subcutaneous adipose connective tissue, usually coupled with bruising, pain, and edema. Lipedema molecular pathophysiology is currently not clear, but several studies suggest that genetics and hormonal imbalance participate in lipedema pathogenesis. Women with lipedema present in some cases with elevated body mass index, and the appearance of obesity in addition to lipedema, where the obesity can cause serious health issues as in lipedema-free individuals with obesity, such as diabetes and cardiovascular disorders. Unlike obesity, lipedema tissue does not respond well to diet or physical exercise alone. Therefore, in this review we discuss the effect of various dietary supplements that, along with diet and physical exercise, cause fat burning and weight loss, and which could potentially be important in the treatment of lipedema. Indeed, an effective fat burner should convert stored fats into energy, mobilize and break down triglycerides in adipocytes, boost metabolism and inhibit lipogenesis. Common ingredients of fat burning supplements are green tea, caffeine, chromium, carnitine, and conjugated linoleic acid. The use of fat burners could act synergistically with a healthy diet and physical exercise for decreasing adipose tissue deposition in patients with lipedema and resolve related health issues. The effects of fat burners in human studies are sometimes contradictory, and further studies should test their effectiveness in treating lipedema.
Keywords: Dietary supplements; Fat burners; Fat burning supplements; Weight loss in lipedema.
©2022 Pacini Editore SRL, Pisa, Italy.
References
-
- Buso G, Depairon M, Tomson D, Raffoul W, Vettor R, Mazzolai L. Lipedema: a call to action! Obesity 2019;27:1567-76. https://doi.org/10.1002/oby.22597 10.1002/oby.22597 - DOI - PMC - PubMed
-
- la Torre YS-D, Wadeea R, Rosas V, Herbst KL. Lipedema: friend and foe. Horm Mol Biol Clin Investig 2018;33. https://doi.org/10.1515/hmbci-2017-0076 10.1515/hmbci-2017-0076 - DOI - PMC - PubMed
-
- Michelini S, Herbst KL, Precone V, Manara E, Marceddu G, Dautaj A, Maltese PE, Paolacci S, Ceccarini MR, Beccari T, Sorrentino E, Aquilanti B, Velluti V, Matera G, Gagliardi L, Miggiano GAD, Bertelli M. A multi-gene panel to identify lipedema-predisposing genetic variants by a next-generation sequencing strategy. J Pers Med 2022;12. https://doi.org/10.3390/jpm12020268 10.3390/jpm12020268 - DOI - PMC - PubMed
-
- Bonetti G, Paolacci S, Samaja M, Maltese PE, Michelini S, Michelini S, Michelini S, Ricci M, Cestari M, Dautaj A, Medori MC, Bertelli M. Low efficacy of genetic tests for the diagnosis of primary lymphedema prompts novel insights into the underlying molecular pathways. Int J Mol Sci 2022;23:7414. https://doi.org/10.3390/ijms23137414 10.3390/ijms23137414 - DOI - PMC - PubMed
-
- van Esch-Smeenge J, Damstra RJ, Hendrickx AA. Muscle strength and functional exercise capacity in patients with lipoedema and obesity: a comparative study. J Lymphoedema 2017;12:27-31.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical